Financial Highlights: Period Jan – Dec 2009

Sales grew by 21.5% to Rs. 4731 million.  The profit before taxes increased by 5.1% to Rs. 964.5 million. Earnings after taxes increased by 3.9% to Rs. 654.8 million. An amount of Rs. 100.99 million was added to the fixed assets during Jan-Dec 2009. The company has investments in Bank Deposits and Liquid Funds of Rs. 3471 million.

The core of the Pharmaceuticals business comprises of formulations used in area of cardiovascular, metabolic diseases and vitamins. Sales in the Pharmaceuticals business sector grew by 10.5% from Rs. 3189.71 million in Jan to Dec 2008 to Rs. 3525.57 million in Jan to Dec 2009. The Pharmaceuticals sector accounts for 74.5% of the Company’s total sales.

The Chemicals business comprises of Bulk Pharma Compounds and Specialty Pigments. Sales in the Chemicals business grew by 71% from Rs. 704.98 million in Jan to Dec 2008 to Rs. 1205.57 million in Jan to Dec 2009.The Chemicals business sector accounts for 25.5% of the Company’s total sales.